The Food and Drug Administration (FDA) on Friday approved a supplemental New Drug Application for La...

What leads a clinician to conclude that a patient with depression is “treatment resistant” and there...

Two prestigious institutions have recognized the American Journal of Psychiatry (AJP) for publicatio...

While adolescents and adults with a history of childhood victimization tend to be more likely to exp...

Naltrexone, first approved for treatment of opioid addiction, is known to help some patients with al...

“I would never want to have a mental health diagnosis on my record.” That was the signature quote fr...

To what extent should clinicians consider “cost-effectiveness” in the choice of treatment? That’s a ...

Today, President Obama is announcing a host of public and private sector initiatives addressing the ...

Experts say buprenorphine is the ideal medication for opioid addiction—the partial agonist satisfies...